General Infectious Disease
WHO Global Arborvirus Initiative: Where do Infectious Disease Providers Play a Role?
- Variable Dose Thromboprophylaxis May Increase Survival in Patients With COVID-19
- Antibiotic Eradication of P aeruginosa Improves Long-Term Lung Function in CF
- Metformin, Ivermectin, and Fluvoxamine Do Not Prevent Severe COVID-19 Outcomes
- Risk for Uveitis After COVID-19 Vaccination Exists, But Is Low
- Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk
- New-Onset Atrial Fibrillation Profiled in Patients Hospitalized With COVID-19
- Nutrition Labels to Move to Front of Packaging Under Biden Plan
- Canada to Remove All COVID-19 Border Restrictions October 1
- Fidaxomicin Is Superior to Vancomycin for Clostridioides difficile Infection
- Psychiatric Risks Subside Before Neurologic Risks After COVID-19
- Presence of Particulate Prompts Recall of Acyclovir Intravenous Product
- Chronic Liver Disease Mortality Rates Increased During COVID-19 Pandemic
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Sleep Quality Linked to Presence, Intensity of Chronic Postsurgical Pain 
Risankizumab Improves Health-Related Quality of Life in Psoriatic Arthritis
Corticosteroid Dose Predicts Mortality in Rheumatic Diseases Plus Pneumonia
Retifanlimab, HFRT, and Bevacizumab Produce “Encouraging” Results in Recurrent Glioblastoma
Can Pulmonary Embolism Severity Indices Predict COVID-19-Related Adverse Events?
